COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021-2022: a test-negative case-control study.

Authors:
Brazete C; Brazete J; Alves F; Aguiar A; Gonçalves AM and 5 more

Journal:
Public Health

Publication Year: 2023

DOI:
10.1016/j.puhe.2023.02.015

PMCID:
PMC9943732

PMID:
36989570

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Public Health

Abbreviation: Public Health

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Analysis of primary care electronic health record data of people living with hepatitis B virus: inf…
Campbell C; Wang T; Gillespie I and 2 more (2023) - Transparency Score: 4/6
An intra-action review conducted by the CDC Foundation during COVID-19 to evaluate emergency respon…
Bednar H; McMillan S; Seidl M and 2 more (2023) - Transparency Score: 3/6
Assessing the construction of a Healthy City in China: a conceptual framework and evaluation index …
Zhao M; Qin W; Zhang S and 3 more (2023) - Transparency Score: 3/6
COVID-19 vaccine hesitancy in a developing country: prevalence, explanatory factors and implication…
Wynter-Adams D; Thomas-Brown P. (2023) - Transparency Score: 3/6
Depression trajectories during the COVID-19 pandemic in the high-quality health care setting of Swi…
Probst-Hensch N; Jeong A; Keidel D and 2 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests None declared."

Evidence found in paper:

"Funding Ana Aguiar holds a PhD grant (Reference: 2020.09390.BD), co-funded by the 10.13039/501100001871Fundação para a Ciência e a Tecnologia (FCT) and the Fundo Social Europeu (FSE) Program."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025